Data / Form D filings / ARROWHEAD RESEARCH CORP
ARROWHEAD RESEARCH CORP: Form D filings
ARROWHEAD RESEARCH CORP, a biotechnology company in Pasadena, CA, filed 6 Form D notices with the SEC between 2009 and 2013. The latest, on October 22, 2013, reports $64 million sold of a $64 million offering to 11 investors.
Find out what ARROWHEAD RESEARCH CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 225 South Lake Avenue, Suite 1050, Pasadena, CA, 91101
- Phone
- (626) 304-3400
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 879407
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 22, 2013 | New notice | $64,000,000 | $64,000,000 | $0 | 11 | Oct 11, 2013 | sec.gov |
| May 16, 2013 | New notice | $36,000,000 | $36,000,000 | $0 | 16 | May 3, 2013 | sec.gov |
| Sep 30, 2010 | New notice | Indefinite | $0 | Indefinite | 2 | Sep 16, 2010 | sec.gov |
| Jan 29, 2010 | New notice | $3,222,896 | $3,222,896 | $0 | 27 | Dec 11, 2009 | sec.gov |
| Aug 13, 2009 | Amendment | $2,760,000 | $2,760,000 | $0 | 26 | Jul 17, 2009 | sec.gov |
| Aug 3, 2009 | New notice | $2,760,000 | $1,859,250 | $900,750 | 12 | Jul 17, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles McKenney | Director | |
| Christopher Anzalone | Executive Officer, Director | |
| Edward Frykman | Director | |
| Michael S. Perry | Director | |
| Bruce S. Given | Executive Officer | |
| Mauro A. Ferrari | Director | |
| Douglass A. Given | Director | |
| Kenneth A. Myszkowski | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Oct 21, 2013 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ARROWHEAD RESEARCH CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.